LENZ ROBERT A. (Head of R&D) sold 4.2% of their position (13.82K shares) of NEUMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $208.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 10/11/2024ACC: 0001610717-24-000505
Officer· Head of R&D
Since Sep 2023
-13.82K
Net shares
Net seller
$208.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
13.82K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−5.56K
Price / share
$15.01
Trade value
$83.51K
% of position
1.7%
10/9/2024
328.53K→322.97K
Common Stock
Direct
Shares
−8.26K
Price / share
$15.09
Trade value
$124.60K
% of position
2.6%
10/10/2024
322.97K→314.71K
Total
Net shares
−13.82K
Net value
-$208.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 10/9/2024 | S · Sale | −5.56K | $15.01 | $83.51K | 1.7% | 328.53K | 322.97K |
| Common Stock Direct | 10/10/2024 | S · Sale | −8.26K | $15.09 | $124.60K | 2.6% | 322.97K | 314.71K |
| Total | −13.82K | -$208.11K | ||||||
Derivative Transactions0
No derivative transactions reported